Cheaper Migraine Drugs Outperform Newer, More Expensive Options: Oxford Study
By Cara Michelle Miller An Oxford study suggests that triptans are the most effective migraine treatment, outperforming newer, pricier options. For decades, inexpensive painkillers like aspirin and ibuprofen, along with triptans—drugs that narrow blood vessels in the brain to block migraine-triggering chemicals—have been prescribed for migraines. Recently, a new generation of migraine…
More Stories
Analyzing Jin Medical International (NASDAQ:ZJYL) and Predictive Oncology (NASDAQ:POAI)
Predictive Oncology (NASDAQ:POAI – Get Free Report) and Jin Medical International (NASDAQ:ZJYL – Get Free Report) are both small-cap medical...
TFI International (OTCMKTS:TFIFF) Trading Up 1.7% – Should You Buy?
TFI International Inc (OTCMKTS:TFIFF – Get Free Report)’s share price was up 1.7% during trading on Tuesday . The company...
TP ICAP Group (LON:TCAP) Stock Price Down 1.3% – Here’s What Happened
TP ICAP Group PLC (LON:TCAP – Get Free Report) dropped 1.3% on Tuesday . The company traded as low as...
SANUWAVE Health (OTCMKTS:SNWV) Trading Up 2.1% – Still a Buy?
SANUWAVE Health, Inc. (OTCMKTS:SNWV – Get Free Report)’s stock price rose 2.1% during trading on Tuesday . The company traded...
ProSiebenSat.1 Media (ETR:PSM) Shares Down 0.4% – Time to Sell?
Shares of ProSiebenSat.1 Media SE (ETR:PSM – Get Free Report) traded down 0.4% on Tuesday . The stock traded as...
LEG Immobilien (FRA:LEG) Shares Down 1.3% – What’s Next?
Shares of LEG Immobilien SE (FRA:LEG – Get Free Report) were down 1.3% during mid-day trading on Tuesday . The...